Trial Profile
A phase I clinical trial of AT 26893 in patients with hepatitis C virus infections.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 Oct 2012
Price :
$35
*
At a glance
- Drugs AT 26893 (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Oct 2012 New trial record